Dostinex

Indicated for neurological hormonal balance, this product is designed to target prolactin levels and utilized to support endocrine function.

Strengths: 0.25 · 0.5mg

Medicine details

Therapeutic class

Dopamine Agonist

Pharmacological class

Ergot Derivative

Known off-label uses

parkinson's disease

Contraindications

uncontrolled hypertension; history of valvular heart disease

Precautions and warnings

regular cardiovascular monitoring required; avoid alcohol

Minor side effects

nausea; dizziness

Moderate side effects

headache; constipation; somnolence

Dosage forms

Tablet

Administration route

Oral use

Prescription status

POM

Manufacturer

Pfizer

Onset Time

3 hours

Duration

7–14 days

Storage instructions

Store below 25°C in a dry place.

Drug interactions

antipsychotics; metoclopramide

Age restrictions

Not recommended for children.

Pregnancy and breastfeeding

Discuss with doctor; generally discontinued upon suspected pregnancy.

Serious side effects

valvular heart disease — requires immediate medical attention; fibrotic disorders — requires immediate medical attention

Patient summary

Indicated for neurological hormonal balance, this product is designed to target prolactin levels and utilized to support endocrine function.

Mechanism of action

This medicine is a dopamine agonist derived from ergot. It acts on dopamine receptors in the pituitary gland to inhibit the secretion of prolactin, effectively reducing high blood levels of this hormone.

Dostinex

Indicated for neurological hormonal balance, this product is designed to target prolactin levels and utilized to support endocrine function.

Editorial Notes

  • Active ingredient(s): Cabergoline
  • Listed indication(s): Hyperprolactinaemia, Prolactinoma

Usually available as

  • 16 tablets - 0.25 mg189-0-25-mg-2772
  • 8 tablets - 0.5 mg189-0-5-mg-1043